David Silberstein
Patrimonio netto: - $ in data 31/05/2026
Patrimonio netto: - $ in data 31/05/2026
David S.
Silberstein currently works at Lantern Pharma, Inc., as Independent Director from 2018, Biological Mimetics, Inc., as Director from 2016, and BioMimetix Pharmaceutical, Inc., as Chief Operating Officer from 2013.
Dr. Silberstein received his doctorate degree from The Trustees of Columbia University in The City of New York.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
LANTERN PHARMA, INC. -.--% | 17/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| LANTERN PHARMA INC. | Direttore/Membro del Consiglio | 01/06/2018 |
BioMimetix Pharmaceutical, Inc.
BioMimetix Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services Provides development services for biopharmaceutical products | Direttore operativo | 01/01/2013 |
Biological Mimetics, Inc.
Biological Mimetics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direttore/Membro del Consiglio | 01/01/2016 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioMimetix Pharmaceutical, Inc.
BioMimetix Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services Provides development services for biopharmaceutical products | Commercial Services |
Lantern Pharma, Inc.
Lantern Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer drug from advanced genomics and artificial intelligence | Health Technology |
Biological Mimetics, Inc.
Biological Mimetics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale